Abstract
INTRODUCTION: Patients with type 2 diabetes mellitus (T2DM) have an increased risk of fracture as compared to patients without T2DM. It has been suggested based on clinical trial data that use of dipeptidyl peptidase-4 inhibitors (DPP4-Is), an anti-hyperglycaemic drug, is associated with a decreased risk of fracture as compared to
... read more